HB 664 – Maryland

Status: Inactive / Dead
Year Introduced: 2020
Link: http://mgaleg.maryland.gov/mgawebsite/Legislation/Details/HB0664?ys=2020RS

Pharmacists – Required Notification and Authorized Substitution – Lower-Costing Drugs, Medical Devices, and Biological Products. Requiring a pharmacist or a pharmacist’s designee who is under certain supervision to inform a certain consumer of the availability of certain therapeutically equivalent drugs, substantially equivalent medical devices, or interchangeable biological products and the cost difference between those drugs, devices, or products and certain prescribed drugs, medical devices, or biological products; etc.

Return to Database Search

© 2018- The SLIHCQ DatabaseInitial funding for this project was provided by the Robert Wood Johnson Foundation. The views expressed here do not necessarily reflect the views of the Foundation.

Associated Litigation:

No items found